title: Using Medicare administrative data to conduct postmarketing surveillance of follow-on biologics: issues and opportunities.
authors: Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
authors: Lisa D
authors: LD
authors: DiMartino
authors: Lesley H
authors: LH
authors: Curtis
authors: Roger L
authors: RL
authors: Williams
authors: Darrell R
authors: DR
authors: Abernethy
authors: Kevin A
authors: KA
authors: Schulman
mesh_terms: D001688:Biological Products / Q000009:adverse effects* / Q000627:therapeutic use; D017277:Drug Approval / Q000379:methods*; D049228:Healthcare Common Procedure Coding System; D006801:Humans; D007344:Insurance Claim Reporting; D038801:International Classification of Diseases; D017387:Investigational New Drug Application / Q000379:methods*; D006278:Medicare; D011358:Product Surveillance, Postmarketing / Q000379:methods*; D013810:Therapeutic Equivalency; D014481:United States
chemical_list: D001688:Biological Products